First part of European fake fighting database linked to securPharm

By Gareth Macdonald

- Last updated on GMT

EMVS linked to German drug database
EMVS linked to German drug database

Related tags European union

The first part of a Europe-wide database intended to help identify fake drugs is operational after being linked to Germany’s securPharm system.

The idea behind the database – known as the European Medicines Verification System (EMVS) is to provide EU member states with details of ‘special features’ used to identify legitimate drug products that can be used to find fakes circulating in the country.

Development of the system – which is called for under the 2011Falsified Medicines Directive (FMD)​ – is being managed by the European Medicines Verification Organisation (EMVO), a non-profit group which was set up by EAEPC, EFPIA, EGA, GIRP and PGEU in February.

The EMVO has subcontracted various software firms to work on the database – including Solidsoft​ Reply which used Microsoft’s Azure tech to develop the system - with the aim being to connect portals in member states to a centrally managed hub.

German database

The securPharm system was set up by German industry groups in 2013 to help pharmaceutical manufacturers, pharmacists and patients in the country detect fakes. The system holds details of codes used to identify legitimate products.

As a result of being linked to the German securPharm network, EMVS can now serve as a central entry point for companies to submit serialisation data according to the EMVO.

Interim director general Andreas Walter said the system “is now capable of comprehensibly: securing cross-border trade; ensuring interoperability between national systems; supporting the establishment of standard interfaces.

He added that it will provide “cost savings for connecting manufacturers at a single entry point.​”

Other contractors supporting the EMVS project include Aegate Holding Limited and Arvato Systems, which have both been involved in database development.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us


View more